Sort
40,608 grants matching “prostate cancer”
Immune activation by necroptotic cell death
$408,808Andrew Atwell Oberst · University Of Washington · R01 · FY2022 · CA
Community Outreach and Engagement
$408,771Elizabeth Bouchard · Roswell Park Cancer Institute Corp · P30 · FY2024 · CA
MECHANISM OF ACTIVATION BY NUCLEAR RECEPTOR COACTIVATORS
$408,765University Of Southern California · R01 · FY2001 · DK
EASTERN COOPERATIVE ONCOLOGY GROUP
$408,759Daniel G Haller · University Of Pennsylvania · U10 · FY2007 · CA
Towards Understanding Prostate Cancer Heterogeneity
$408,737Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA
EVALUATING THE ROLE OF GENETIC MARKERS IN PROSTATE CANCER PROGRESSION: A MULTIETHNIC COHORT EXPERIENCE
$408,716The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2008 · Department of Defense
Social Determinants of Health Research Project
$408,701Ashley Housten · Washington University · U19 · FY2024 · CA
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
$408,699Loic Le Marchand · University Of Hawaii At Manoa · U01 · FY2019 · CA
Core A: Pathobiology Core
$408,681Massimo F Loda · Columbia University Health Sciences · P01 · FY2023 · CA
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
$408,667Stephan E Maier · Brigham And Women'S Hospital · R01 · FY2012 · CA
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
$408,656Arun Sreekumar · Baylor College Of Medicine · R01 · FY2019 · CA
Genetics of Prostate Cancer Risk &Agressiveness
$408,655Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
Determining the role of lipid droplets in glioblastoma and their therapeutic potential
$408,589Deliang Guo · Ohio State University · R01 · FY2020 · NS
Determining the role of lipid droplets in glioblastoma and their therapeutic potential
$408,589Deliang Guo · Ohio State University · R01 · FY2019 · NS
Determining the role of lipid droplets in glioblastoma and their therapeutic potential
$408,589Deliang Guo · Ohio State University · R01 · FY2022 · NS
Determining the role of lipid droplets in glioblastoma and their therapeutic potential
$408,589Deliang Guo · Ohio State University · R01 · FY2021 · NS
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
$408,564Gail E Sonenshein · Boston University Medical Campus · R01 · FY2006 · CA
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2015 · GM
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2016 · GM
Programmable DNA Binding Oligomers for Control of Transcription
$408,538Peter B. Dervan · California Institute Of Technology · R01 · FY2017 · GM
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$408,530Arnold I. Caplan · Case Western Reserve University · R01 · FY2022 · CA
Precise MRI-Directed Sonic Ablation of Prostate Cancer
$408,482Stanford University · R01 · FY2005 · CA
Programmable DNA Binding Oligomers for Control of Transcription
$408,426Peter B. Dervan · California Institute Of Technology · R01 · FY2014 · GM
Integrative molecular imaging and sequencing of prostate cancer
$408,401Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2015 · CA
Establish Mouse Models to Evaluate Androgen Deprivation Therapy on AD
$408,375Lizhong Wang · University Of Alabama At Birmingham · R21 · FY2020 · AG